跳至主要内容
临床试验/EUCTR2014-000991-25-GB
EUCTR2014-000991-25-GB进行中(未招募)1 期

Pre-surgical metformin for women with endometrial cancer: a randomised placebo controlled trial - Metformin for endometrial cancer RCT

Central Manchester University Hospitals NHS Foundation Trust0 个研究点目标入组 90 人开始时间: 2014年8月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1. Biopsy-proven type 1 endometrial carcinoma or severe atypical hyperplasia
  • 2. Scheduled surgical treatment by hysterectomy n 5-35 days' time
  • 3. Informed consent
  • 4. Aged 18 years or more
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 45
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 45

排除标准

  • 1. Current treatment with metformin
  • 2. Diabetic on hypoglycaemic medication
  • 3. Inability to consent due to lack of capacity or language barriers
  • 4. Unable to comply with treatment protocol
  • 5. Type 2 endometrial cancer
  • 6. Severe renal impairment (Serum creatinine >130umol/L or eGFR <45ml/min/1.732m2)
  • 7. Severe hepatic impairment (abnormal LFTs to be discussed on case by case basis with hepatologist)
  • 8. Current alcohol abuse
  • 9. Sensitivity/hypersensitivity to biguanides
  • 10. Current treatment with other mTOR inhibitors or chemotherapeutic agents

研究者

相似试验

已完成
3 期
PREMIUM (PRE-Surgical Metformin In Uterine Malignancies) studyTopic: CancerSubtopic: Gynaecological CancerDisease: Uterus/EndometriumCancer
ISRCTN88589234Central Manchester University Hospitals NHS Trust (CMFT)90
进行中(未招募)
1 期
Metformin treatment before IVF in women with ultrasound evidence of polycystic ovaries; a prospective, randomised, double blind, placebo controlled study
EUCTR2005-000500-13-GBniversity of Oxford- Research Services140
进行中(未招募)
1 期
PregMet 2 studyPoly Cystic Ovarial Syndrome (PCOS) in pregnant women. PCOS should be diagnosed according to the Rotterdam Consensus criterias:- at least 2 out of 3 criterias1.PCO in at least one ovary2.Oligo-/anovulation (clinically diagnosed as oligo-/amenorrhea,i.e. menstrual cycles > 35 days or <10 menstruations/year3.Hyperandrogenismclinical or biochemicalMedDRA version: 14.1Level: LLTClassification code 10065161Term: Polycystic ovarian syndromeSystem Organ Class: 100000004872
EUCTR2011-002203-15-SETNU, Norwegian University of Science and Technology1,000
进行中(未招募)
1 期
PregMet 2 study
EUCTR2011-002203-15-ISTNU, Norwegian University of Science and Technology1,000
进行中(未招募)
1 期
PregMet 2 studyPoly Cystic Ovarial Syndrome (PCOS) in pregnant women. PCOS should be diagnosed according to the Rotterdam Consensus criterias: - at least 2 out of 3 criterias 1.PCO in at least one ovary 2.Oligo-/anovulation (clinically diagnosed as oligo-/amenorrhea,i.e. menstrual cycles > 35 days or <10 menstruations/year 3.Hyperandrogenismclinical or biochemicalMedDRA version: 20.0 Level: LLT Classification code 10065161 Term: Polycystic ovarian syndrome System Organ Class: 100000004872
EUCTR2011-002203-15-NOTNU, Norwegian University of Science and Technology1,000